Cover Image
市場調查報告書

Cellceutix Corporation :產品平台分析

Cellceutix Corporation - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 283209
出版日期 內容資訊 英文 157 Pages
訂單完成後即時交付
價格
Back to Top
Cellceutix Corporation :產品平台分析 Cellceutix Corporation - Product Pipeline Review - 2016
出版日期: 2016年08月24日 內容資訊: 英文 157 Pages
簡介

Cellceutix Corporation是致力於解決腫瘤學,抗菌,皮膚科學領域上之醫學性未滿足需求所用的小分子療法之臨床階段生物製藥企業。該公司的產品用於惡化型固態癌症、急性骨髓性白血病、口腔粘膜炎、皮膚感染疾病、乾癬等治療上。

本報告提供Cellceutix Corporation 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Cellceutix Corporation的基本資料

  • Cellceutix Corporation概要
  • 主要資訊
  • 企業資料

Cellceutix Corporation :R&D概要

  • 主要的治療範圍

Cellceutix Corporation :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Cellceutix Corporation :開發中產品概況

  • 臨床實驗階段的開發中產品
  • 初期階段的開發中產品

Cellceutix Corporation :藥物簡介

  • brilacidin
  • Kevetrin
  • KM-133
  • CTIX-1278
  • CTIX-1807
  • KM-277
  • KM-278
  • KM-3174
  • KM-362
  • KM-391
  • KM-732
  • PMX-0196
  • PMX-0231
  • PMX-0243
  • PMX-10072
  • PMX-10098
  • PMX-1207
  • PMX-1241
  • PMX-1278
  • PMX-1405
  • PMX-1408
  • PMX-1502
  • PMX-20005
  • PMX-207
  • PMX-225
  • PMX-496
  • PMX-504
  • PMX-519
  • PMX-611
  • PMX-647
  • PMX-835
  • PMX-100
  • PMX-10070
  • PMX-1014
  • PMX-1045
  • PMX-1056
  • PMX-1057
  • PMX-1090
  • PMX-1091
  • PMX-1094
  • PMX-1099
  • PMX-1102
  • PMX-1142
  • PMX-1363
  • PMX-1424
  • PMX-1442
  • PMX-1445
  • PMX-1467
  • PMX-1488
  • PMX-1533
  • PMX-1547
  • PMX-1555
  • PMX-1560
  • PMX-1570
  • PMX-1572
  • PMX-1573
  • PMX-1576
  • PMX-1591
  • PMX-1625
  • PMX-183
  • PMX-223
  • PMX-229
  • PMX-247
  • PMX-255
  • PMX-30016
  • PMX-30024
  • PMX-520
  • PMX-633
  • PMX-668
  • PMX-693
  • PMX-70004
  • PMX-728
  • PMX-741
  • PMX-843
  • PMX-868

Cellceutix Corporation :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Cellceutix Corporation :最近的開發平台趨勢

Cellceutix Corporation :暫停中的計劃

Cellceutix Corporation :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08125CDB

Summary

Global Markets Direct's, 'Cellceutix Corporation - Product Pipeline Review - 2016', provides an overview of the Cellceutix Corporation's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Cellceutix Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Cellceutix Corporation
  • The report provides overview of Cellceutix Corporation including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Cellceutix Corporation's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Cellceutix Corporation's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Cellceutix Corporation's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Cellceutix Corporation
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Cellceutix Corporation's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Cellceutix Corporation Snapshot
    • Cellceutix Corporation Overview
    • Key Information
    • Key Facts
  • Cellceutix Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Cellceutix Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Cellceutix Corporation - Pipeline Products Glance
  • Cellceutix Corporation - Clinical Stage Pipeline Products
  • Cellceutix Corporation - Early Stage Pipeline Products
  • Cellceutix Corporation - Drug Profiles
    • brilacidin tetrahydrochloride
    • KM-133
    • KM-3174
    • CC-1807
    • CTIX-1278
    • CTIX-1502
    • KM-277
    • KM-278
    • KM-362
    • KM-391
    • KM-732
    • PMX-0196
    • PMX-0243
    • PMX-10072
    • PMX-10098
    • PMX-1207
    • PMX-1241
    • PMX-1278
    • PMX-1405
    • PMX-1408
    • PMX-20005
    • PMX-207
    • PMX-225
    • PMX-231
    • PMX-255
    • PMX-30016
    • PMX-30024
    • PMX-496
    • PMX-504
    • PMX-519
    • PMX-611
    • PMX-647
    • PMX-835
    • Small Molecule to Disrupt Cell Membrane for Hidradenitis Suppurativa
    • PMX-100
    • PMX-1014
    • PMX-1045
    • PMX-1056
    • PMX-1057
    • PMX-1090
    • PMX-1091
    • PMX-1094
    • PMX-1099
    • PMX-1102
    • PMX-1142
    • PMX-1363
    • PMX-1424
    • PMX-1442
    • PMX-1445
    • PMX-1467
    • PMX-1488
    • PMX-1533
    • PMX-1547
    • PMX-1555
    • PMX-1560
    • PMX-1570
    • PMX-1572
    • PMX-1573
    • PMX-1576
    • PMX-1591
    • PMX-1625
    • PMX-183
    • PMX-223
    • PMX-229
    • PMX-247
    • PMX-520
    • PMX-633
    • PMX-668
    • PMX-693
    • PMX-70004
    • PMX-728
    • PMX-741
    • PMX-843
    • PMX-868
  • Cellceutix Corporation - Pipeline Analysis
    • Cellceutix Corporation - Pipeline Products by Target
    • Cellceutix Corporation - Pipeline Products by Route of Administration
    • Cellceutix Corporation - Pipeline Products by Molecule Type
    • Cellceutix Corporation - Pipeline Products by Mechanism of Action
  • Cellceutix Corporation - Recent Pipeline Updates
  • Cellceutix Corporation - Dormant Projects
  • Cellceutix Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Cellceutix Corporation, Key Information
  • Cellceutix Corporation, Key Facts
  • Cellceutix Corporation - Pipeline by Indication, 2016
  • Cellceutix Corporation - Pipeline by Stage of Development, 2016
  • Cellceutix Corporation - Monotherapy Products in Pipeline, 2016
  • Cellceutix Corporation - Phase II, 2016
  • Cellceutix Corporation - Phase I, 2016
  • Cellceutix Corporation - Preclinical, 2016
  • Cellceutix Corporation - Discovery, 2016
  • Cellceutix Corporation - Pipeline by Target, 2016
  • Cellceutix Corporation - Pipeline by Route of Administration, 2016
  • Cellceutix Corporation - Pipeline by Molecule Type, 2016
  • Cellceutix Corporation - Pipeline Products by Mechanism of Action, 2016
  • Cellceutix Corporation - Recent Pipeline Updates, 2016
  • Cellceutix Corporation - Dormant Developmental Projects,2016

List of Figures

  • Cellceutix Corporation - Pipeline by Top 10 Indication, 2016
  • Cellceutix Corporation - Pipeline by Stage of Development, 2016
  • Cellceutix Corporation - Monotherapy Products in Pipeline, 2016
  • Cellceutix Corporation - Pipeline by Target, 2016
  • Cellceutix Corporation - Pipeline by Route of Administration, 2016
  • Cellceutix Corporation - Pipeline by Molecule Type, 2016
  • Cellceutix Corporation - Pipeline Products by Mechanism of Action, 2016
Back to Top